These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22013729)

  • 41. Hepatitis C virus infection in patients with tuberculosis in Central Brazil.
    Reis NR; Lopes CL; Teles SA; Matos MA; Carneiro MA; Marinho TA; Filho JA; Espírito-Santo MP; Lampe E; Martins RM
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1397-402. PubMed ID: 22283901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4.
    Marascio N; Mazzitelli M; Pavia G; Giancotti A; Barreca GS; Costa C; Pisani V; Greco G; Serapide F; Trecarichi EM; Casalinuovo F; Liberto MC; Matera G; Torti C
    Cells; 2019 May; 8(5):. PubMed ID: 31060315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C.
    Yang CHT; Goel A; Ahmed A
    Adolesc Health Med Ther; 2018; 9():103-110. PubMed ID: 30104913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laboratory Biomarkers to Facilitate Differential Diagnosis between Measles and Kawasaki Disease in a Pediatric Emergency Room: A Retrospective Study.
    Buonsenso D; Macchiarulo G; Supino MC; La Penna F; Scateni S; Marchesi A; Reale A; Boccuzzi E
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018033. PubMed ID: 29755710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.
    Yang CHT; Yoo ER; Ahmed A
    J Clin Transl Hepatol; 2017 Mar; 5(1):59-66. PubMed ID: 28507928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New treatments for chronic hepatitis C: an overview for paediatricians.
    Serranti D; Indolfi G; Resti M
    World J Gastroenterol; 2014 Nov; 20(43):15965-74. PubMed ID: 25473150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of children with chronic viral hepatitis: what is available and what is in store.
    Vajro P; Veropalumbo C; Maddaluno S; Salerno M; Parenti G; Pignata C
    World J Pediatr; 2013 Aug; 9(3):212-20. PubMed ID: 23929253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
    Domagalski K; Pawłowska M; Tretyn A; Halota W; Pilarczyk M; Smukalska E; Linkowska K; Grzybowski T
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):745-54. PubMed ID: 23314745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child?
    Serranti D; Buonsenso D; Ceccarelli M; Gargiullo L; Ranno O; Valentini P
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1057-67. PubMed ID: 22013729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
    Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
    Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C in childhood.
    Sibal A; Mishra D; Arora M
    J Indian Med Assoc; 2002 Feb; 100(2):93-8. PubMed ID: 12206357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.